AXA saves $182K in six months with RPA

Bluejay Therapeutics bags $182 million financing to propel clinical pi $182 Sionna secures $182M series C to more than double its clinical-stage cystic fibrosis contenders Sionna Therapeutics has closed a $182 million $182 Bluejay Therapeutics bags $182 million financing to propel clinical pipeline

convert $182 Bluejay Therapeutics, a San Mateo, CA-based company which specializes in the development of novel therapeutics, raised $182M in Series C